Correlation Between Spyre Therapeutics and Aytu BioScience
Can any of the company-specific risk be diversified away by investing in both Spyre Therapeutics and Aytu BioScience at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Spyre Therapeutics and Aytu BioScience into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Spyre Therapeutics and Aytu BioScience, you can compare the effects of market volatilities on Spyre Therapeutics and Aytu BioScience and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Spyre Therapeutics with a short position of Aytu BioScience. Check out your portfolio center. Please also check ongoing floating volatility patterns of Spyre Therapeutics and Aytu BioScience.
Diversification Opportunities for Spyre Therapeutics and Aytu BioScience
-0.3 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Spyre and Aytu is -0.3. Overlapping area represents the amount of risk that can be diversified away by holding Spyre Therapeutics and Aytu BioScience in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aytu BioScience and Spyre Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Spyre Therapeutics are associated (or correlated) with Aytu BioScience. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aytu BioScience has no effect on the direction of Spyre Therapeutics i.e., Spyre Therapeutics and Aytu BioScience go up and down completely randomly.
Pair Corralation between Spyre Therapeutics and Aytu BioScience
Given the investment horizon of 90 days Spyre Therapeutics is expected to generate 0.89 times more return on investment than Aytu BioScience. However, Spyre Therapeutics is 1.12 times less risky than Aytu BioScience. It trades about -0.13 of its potential returns per unit of risk. Aytu BioScience is currently generating about -0.16 per unit of risk. If you would invest 3,253 in Spyre Therapeutics on September 1, 2024 and sell it today you would lose (410.00) from holding Spyre Therapeutics or give up 12.6% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Spyre Therapeutics vs. Aytu BioScience
Performance |
| Timeline |
| Spyre Therapeutics |
| Aytu BioScience |
Spyre Therapeutics and Aytu BioScience Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Spyre Therapeutics and Aytu BioScience
The main advantage of trading using opposite Spyre Therapeutics and Aytu BioScience positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Spyre Therapeutics position performs unexpectedly, Aytu BioScience can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aytu BioScience will offset losses from the drop in Aytu BioScience's long position.| Spyre Therapeutics vs. Tff Pharmaceuticals | Spyre Therapeutics vs. Eliem Therapeutics | Spyre Therapeutics vs. Inhibrx | Spyre Therapeutics vs. Enliven Therapeutics |
| Aytu BioScience vs. Aquestive Therapeutics | Aytu BioScience vs. Evoke Pharma | Aytu BioScience vs. Shionogi Co Ltd | Aytu BioScience vs. Sunshine Biopharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Other Complementary Tools
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon |